{
  "ptid_time": "011_S_4366_2011-11-14",
  "img_path": "/data/qiuhui/data/adni/images/011_S_4366/2011-11-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 89,177 mm³, 131.5% above the reference mean. With a Z-score of 3.15 (99.9th percentile), this represents profound enlargement; hippocampal volume measures 5,854 mm³, 22.6% below the reference mean. With a Z-score of -2.20 (1.4th percentile), this represents significant atrophy; whole brain volume measures 1,087,290 mm³, 0.7% above the reference mean. With a Z-score of 0.09 (53.8th percentile), this represents normal volume ; entorhinal cortex volume measures 4,652 mm³, 13.4% above the reference mean. With a Z-score of 0.91 (81.9th percentile), this represents normal volume ; fusiform gyrus volume measures 18,735 mm³, 0.5% below the reference mean. With a Z-score of -0.05 (48.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,865 mm³, 11.6% below the reference mean. With a Z-score of -1.04 (14.9th percentile), this represents mild atrophy. ",
  "text_data": "Age is 73.6 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Major Surgical Procedures. MMSE: 26.0. MoCA: 16.0. Logical Memory: 1.0. Laboratory findings: Eosinophils: 0.42 (profound elevated); Basophils: 0.09 (significant elevated); Eosinophils: 6.60 (significant elevated); Basophils: 1.40 (significant elevated); Phosphorus: 2.30 (significant reduced). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.54 SUVR (profound elevated); Amyloid beta: 729.90 pg/mL (normal ); Total tau: 449.90 pg/mL (significant elevated); Phosphorylated tau: 46.64 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant hippocampal atrophy (Z-score -2.20) and profound ventricular enlargement (Z-score 3.15), both strong indicators of neurodegeneration. Combined with elevated T-tau, P-tau, and AV45 (suggesting amyloid pathology), along with cognitive impairment (MoCA 16.0), this strongly suggests Alzheimer's pathology despite normal Aβ levels (possibly due to a different Aβ assay or advanced disease stage).  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Note: The normal Aβ is atypical for typical AD but could reflect a non-amyloidogenic subtype, assay variability, or advanced disease where plaques plateau. The tau and neurodegeneration markers, along with imaging, strongly support AD pathology.)*",
  "timestamp": "2025-07-25T22:57:56.207295"
}